Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron buys into Biometric's cell imaging

This article was originally published in Clinica

Executive Summary

Biometric Imaging is to develop applications of its Imagn 2000 microvolume fluorometry cellular analysis technology for Chiron under a preferred partnership agreement. Microvolume fluorometry is a laser-based imaging system for detecting fluorescently-tagged cells held in stasis in a small volume of media. Chiron has made an undisclosed equity investment in Biometric, in exchange for first refusal on applications in oncology, infectious disease and haematopoietic cells.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel